INTERNATIONAL NASH DAY

On June 12 2018, The NASH Education Program launched the public education campaign “International NASH Day” to raise visibility and urgency around fatty liver disease and its more advanced form, non alcoholic steatohepatitis (NASH), which affects more than 115 million people around the world.1,2

Following the large success of the first edition and to build upon stakeholders’ engagement, The NASH Education Program convened a coalition of patient advocacy associations, medical and professional societies, to organize the future editions of International NASH Day under the leadership of the Global Liver Institute.

THROWBACK ON THE 2ND EDITION OF INTERNATIONAL NASH DAY

To celebrate the 2nd edition of International NASH Day, The NASH Education Program hosted a conference in Brussels and New York City. Over 200 attendees joined us in person or online.

Find out more information about the conferences and watch the replay below:

New York City

NASH, a looming public health crisis: Identifying challenges and building a common vision for the diagnosis and management of high risk patients

https://youtube.com/watch?v=n0oAW1CHt8c%3Ffeature%3Doembed
Program:

Introduction

NASH, a looming public health crisis
– NASH: what is it and what are the outcomes?
– Epidemiology and socio-economic burden of NASH

Challenges in the current practices for the diagnosis and
management of high risk population
– Lack of awareness in the patient and healthcare communities
– Lack of treatment options
– Lack of guidance/recommendation for high risk population & current bottleneck with diagnosis

What is on the horizon for NASH diagnostic
– New diagnostics programs
– Creating a standard of care

Panel Discussion – Unmet needs and building consensus
– “Beyond the biopsy” campaign – Global Liver Institute
– Panel discussion with physicians and patients

Conclusion

Speakers:
  • Moderator: Dr. Nicole Harris-Hollingsworth, Montefiore Health
    System – Albert Einstein College of Medicine
  • Dr. Julia Wattacheril, Columbia University Irving Medical Center
  • Dr. Amreen Dinani, Mount Sinai
  • Dr. Amon Asgharpour, Mount Sinai
  • Richard Gelula, Global Liver Institute

Brussels

NASH, a looming public health crisis: What are the challenges for health authorities and the medical community?

https://youtube.com/watch?v=l5z1BgQxon0%3Ffeature%3Doembed
Program:

Introduction

NASH, a looming public health crisis
– NASH: what is it and what are the outcomes?
– Epidemiology and socio-economic burden of NASH

Challenges to raise public awareness
– A patient testimony
– The importance of raising awareness: a patient perspective
– Strategy to raise public and governmental awareness

Challenges for the medical community
– Challenges in NASH diagnosis
– Challenge of multidisciplinary approach: a practical example

Q&A and Conclusion

Speakers:
  • Prof. Sven Francque, M.D. PhD – Professor & Chair, Antwerp University Hospital (Belgium)
  • Prof. Jörn Schattenberg, M.D. – Assistant Professor of Medicine at the University Medical Center Mainz (Germany)
  • Prof. Massimo Colombo – Chairman of the EASL International Liver Foundation (EASL-ILF)
  • Prof. Jeffrey Lazarus – Vice-Chairman of the EASL International Liver Foundation (EASL-ILF)
  • Marko Korenjak – President of European Liver Patients Association (ELPA)
  • Julio Burman – Vice-President of European Liver Patients Association (ELPA)
  • M. Jan F., a patient followed by Prof. Sven Francque

THROWBACK ON THE 1ST INTERNATIONAL NASH DAY

The NASH Education Program coordinated over 50 events from liver health screenings, policy briefings, and educational events online and in more than 25 cities across the globe.

The NASH Education Program also produced Web-TV featuring world-renowned leaders in the field of NASH. The Web-TV is an easy-to-understand program available in seven languages, designed to educate the public about NAFLD & NASH.

Find out more about the 2018 edition.

https://youtube.com/watch?v=QQcOZ1whKto%3Ffeature%3Doembed
https://youtube.com/watch?v=ND3AVP3Au0w%3Ffeature%3Doembed
https://youtube.com/watch?v=luYVhG679QU%3Ffeature%3Doembed
https://youtube.com/watch?v=nAjMRjDaD24%3Ffeature%3Doembed
https://youtube.com/watch?v=x_nwFXuRgyU%3Ffeature%3Doembed
https://youtube.com/watch?v=Sl9Fu-QNxco%3Ffeature%3Doembed
https://youtube.com/watch?v=rWS-cAULzgE%3Ffeature%3Doembed
https://youtube.com/watch?v=vDt5kHXgWEk%3Ffeature%3Doembed

Want to learn more about NAFLD & NASH?

WATCH OUR
EDUCATIONAL VIDEOS

References

  1. Younossi, ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease -Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.
  2. United States Census Bureau. Current population 2019. https://www.census.gov/popclock/print.php?component=counter&image=https://www.census.gov/images/census-logo-whiteBG.png. Accessed October 11, 2019.